{
  "date": "2020-12-28",
  "note_type": "Progress Notes",
  "text": "Chemo/outpatient flow sheet\n\nName: Jane M. Doe  \nMRN: 0001024407  \nDiagnosis: Stage II Breast Cancer  \n\nHeight:  \nHT readings from last 1 encounter:  \n2020-11-17: 1.59 m (5' 2.6\")  \n\nAllergies: No known allergies  \n\nPhysician: Dr. Scott  \nDate: 2020-12-28  \n\nWeight: 79.8 kg (176 lb)  \n\nRecent Lab Values:  \n- White Blood Count (thou/cu mm):  \n  2020-12-27: 6.0  \n- Hemoglobin (g/dl):  \n  2020-12-27: 12.5  \n- Platelet Count (thou/cu mm):  \n  2020-12-27: 175  \n- Neut % (% neut):  \n  2020-12-27: 42.1  \n- ANC (absolute neutrophils, thou/cu mm):  \n  2020-12-27: 2.5  \n- Lymph % (% lymph):  \n  2020-12-27: 39.3  \n- Creatinine (mg/dl):  \n  2020-12-27: 1.02  \n\nSymptoms:  \n- Nausea: No  \n- Vomiting: No  \n- Diarrhea: No  \n- Fatigue: No  \n\nCycle: #1  \nDay: 1  \nIV/Port: IV  \n\nMedication Administration:  \n- Pembrolizumab (Keytruda) 200 mg in NaCl 0.9% 100 ml infusion  \n  Dose: 200 mg  \n  Route: Intravenous  \n  Time: 2020-12-28 1406 CST  \n\nAll medication administration completed by: 2020-12-28 1512  \n\nOrders Expiration Date: 2022-12-28  \n\nCopy of orders sent to provider: Yes  \n\nTreatment Plan/Comments:  \nPatient here for Cycle 1, Day 1 of Keytruda treatment. Denies any new concerns at this time. Treatment completed without problems.",
  "id": "5184613c-11f7-4ecb-985a-1920daba51c1"
}